Table 1.
Personal and family medical history in the two study groups.
| Parameter | Total (N = 150) | Cases (N = 50) | Controls (N = 100) | p‐Value | |||
|---|---|---|---|---|---|---|---|
| N | % | N | % | N | % | ||
| Personal medical history | |||||||
| Previous cerebral venous thrombosis (CVT) episodes | 3 | 2.0 | 2 | 4.0 | 1 | 1.0 | 0.258 |
| DVT | 12 | 8.0 | 8 | 8.0 | 8 | 8.0 | 1.000 |
| Hereditary thrombophilia | 7 | 4.7 | 7 | 14.3 | 0 | 0.0 | <0.001* |
| Other thrombotic disorder | 140 | 6.7 | 1 | 2.0 | 9 | 9.0 | 0.166 |
| Hypertension | 6 | 4.0 | 1 | 2.0 | 5 | 5.0 | 0.664 |
| Ischemic heart disease | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | – |
| Diabetes | 5 | 3.4 | 0 | 0.0 | 5 | 5.1 | 0.169 |
| Thyroid disease | 22 | 14.7 | 4 | 8.0 | 18 | 18.0 | 0.142 |
| Sickle cell disease | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | – |
| Cancer | 17 | 11.3 | 2 | 4.0 | 15 | 15.0 | 0.056 |
| Epilepsy | 25 | 16.7 | 14 | 28.0 | 11 | 11.0 | 0.008* |
| Rheumatic disease | 10 | 6.7 | 1 | 2.0 | 9 | 9.0 | 0.166 |
| Myasthenia gravis | 4 | 2.7 | 0 | 0.0 | 4 | 4.0 | 0.102 |
| SLE | 13 | 8.7 | 4 | 8.0 | 9 | 9.0 | 1.000 |
| Nephrotic syndrome | 1 | 0.7 | 1 | 2.0 | 0 | 0.0 | 0.333 |
| Head Trauma | 2 | 1.4 | 1 | 2.0 | 1 | 1.0 | 1.000 |
| Other comorbidities | 43 | 28.7 | 12 | 24.0 | 31 | 31.0 | 0.371 |
| Smoking | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | – |
| Family history | |||||||
| CVT | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | – |
| Thrombophilia | 2 | 1.3 | 2 | 4.0 | 0 | 0.0 | 0.110 |
Abbreviations: DVT, deep vein thrombosis; SLE, systemic lupus erythematosus.
*
Significant p‐value.